Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805473) titled '[18F]F-DED PET Imaging of Reactive Astrocytes in Multiple Sclerosis' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Parc de Salut Mar

Condition: Multiple Sclerosis

Intervention: Drug: [18F]fluorodeprenyl-D2

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 1, 2026

Target Sample Size: 30

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07805473

Published by HT Digital Content Services with pe...